GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 13 filers reported holding GW PHARMACEUTICALS PLC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $21,655,000 | -24.0% | 311,853 | 0.0% | 13.09% | +79.2% |
| Q3 2015 | $28,494,000 | -25.6% | 311,853 | 0.0% | 7.30% | -32.4% |
| Q2 2015 | $38,308,000 | +34.8% | 311,853 | 0.0% | 10.81% | +65.2% |
| Q1 2015 | $28,419,000 | +34.6% | 311,853 | 0.0% | 6.54% | +12.7% |
| Q4 2014 | $21,106,000 | -16.3% | 311,853 | 0.0% | 5.81% | -48.8% |
| Q3 2014 | $25,213,000 | -24.6% | 311,853 | 0.0% | 11.33% | -36.6% |
| Q2 2014 | $33,459,000 | -12.5% | 311,853 | -51.6% | 17.88% | -10.1% |
| Q1 2014 | $38,257,000 | +31.7% | 644,376 | -7.9% | 19.89% | +27.2% |
| Q4 2013 | $29,052,000 | +100.0% | 699,376 | -16.5% | 15.63% | +94.9% |
| Q3 2013 | $14,527,000 | +96.8% | 837,800 | 0.0% | 8.02% | +46.4% |
| Q2 2013 | $7,381,000 | – | 837,800 | – | 5.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |